Lilly's obesity pill tops 7,000 prescriptions in fourth week, signals modest uptake
By Sneha S K May 8 (Reuters) - Eli Lilly's new weight-loss pill, Foundayo, was prescribed 7,335 times in the U.S. in the fourth week, a modest uptake compared to rival Novo Nordisk's Wegovy pill, analysts said. 
